Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These Five Stocks Are Gaining Ground Today

The US stocks rallied on Wednesday after the dovish comments from Federal Reserve Chairwoman Janet Yellen on Tuesday. Among the prominent stocks that registered substantial gains on a strong trading volume are ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Lululemon Athletica inc. (NASDAQ:LULU), Apple Inc. (NASDAQ:AAPL), Vale SA (ADR) (NYSE:VALE), and Gerdau SA (ADR) (NYSE:GGB). Let’s take a closer look at the reasons behind the growth of these stocks and see the smart money sentiment surrounding them.

At Insider Monkey, we track around 730 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) surged by approximately 12% this morning after the U.S. Food and Drug Administration voted 12-2 in the favor of the company regarding its pimavanserin drug for the treatment for psychosis associated with Parkinson’s disease. The FDA committee announced on Tuesday that the benefits of the ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s drug outweigh its risks. The biopharmaceutical company’s stock has jumped to reach its two-month high on the back of the news. Overall, 24 hedge funds tracked by Insider Monkey held positions in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) at the end of fourth quarter and the total value of these positions stood at approximately $928.9 million representing some 25.80% of the company’s stock. Ken Griffin’s Citadel Investment Group owns approximately 1.1 million shares of the company.

Follow Acadia Pharmaceuticals Inc (NASDAQ:ACAD)
Trade (NASDAQ:ACAD) Now!

Canadian yoga-wear retailer Lululemon Athletica inc. (NASDAQ:LULU)’s stock has gained 10% after the company declared fourth-quarter and full-year results for the fiscal year ended January 31, 2016. The company reported fourth-quarter net income of $117.4 million at $0.85 per share, beating the Wall Street’s estimates of 80 cents a share. Revenue jumped by 17% on the year to $704.3 million, easily beating the consensus estimate of $693.8 million. Lululemon expects its revenue to be at $2.34 billion from $2.29 billion for the full year. Diluted earnings per share are estimated to be around $2.05 to $2.15 for the full year. A total of 22 hedge funds out of those tracked by us held long positions in Lululemon Athletica inc. (NASDAQ:LULU) at the end of 2015, versus 33 funds a quarter earlier. The total value of hedge funds’ positions went up to approximately $728.8 million from around $837.3 million. Among the notable shareholders, billionaire Stephen Mandel’s Lone Pine Capital holds around 6 million shares of the company.

Follow Lululemon Athletica Inc. (NASDAQ:LULU)
Trade (NASDAQ:LULU) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.